Green Thumb Industries Inc.
General ticker "GTBIF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $1.7B (TTM average)
Green Thumb Industries Inc. follows the US Stock Market performance with the rate: 19.9%.
Estimated limits based on current volatility of 2.0%: low 6.26$, high 6.55$
Factors to consider:
- Total employees count: 5000 (+4.2%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Economic downturns and volatility, Regulatory and compliance, Product liability claims, Cybersecurity threats, Market competition
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.88$, 10.42$]
- 2026-12-31 to 2027-12-31 estimated range: [6.04$, 10.65$]
Financial Metrics affecting the GTBIF estimates:
- Positive: with PPE of 16.5 at the end of fiscal year the price was neutral
- Positive: 15.29 < Operating cash flow per share per price, % of 15.93
- Positive: 11.29 < Operating profit margin, % of 11.72
- Positive: Industry inventory ratio change (median), % of -0.31 <= 0
- Positive: -7.11 < Investing cash flow per share per price, % of -7.04
- Positive: -51.61 < Industry operating profit margin (median), % of -17.91
- Positive: -6.44 < Industry operating cash flow per share per price (median), % of -1.98
- Positive: Inventory ratio change, % of 0.41 <= 1.34
- Positive: Interest expense per share per price, % of 1.08 <= 1.42
- Positive: 3.48 < Return on assets ratio (scaled to [-100,100]) of 3.99
- Negative: 58.56 < Shareholder equity ratio, % of 68.29 <= 69.38
Short-term GTBIF quotes
Long-term GTBIF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,054.55MM | $1,137.14MM | $1,175.30MM |
| Operating Expenses | $869.92MM | $912.72MM | $1,037.60MM |
| Operating Income | $184.63MM | $224.43MM | $137.70MM |
| Non-Operating Income | $-28.58MM | $-24.29MM | $125.66MM |
| Interest Expense | $19.07MM | $24.27MM | $20.02MM |
| Income(Loss) | $156.05MM | $200.14MM | $263.36MM |
| Taxes | $118.63MM | $126.29MM | $147.30MM |
| Net Income(Loss)* | $36.27MM | $73.08MM | $116.15MM |
| Stockholders Equity | $1,702.88MM | $1,789.28MM | $1,905.43MM |
| Inventory | $112.97MM | $147.16MM | $158.29MM |
| Assets | $2,490.06MM | $2,537.01MM | $2,790.06MM |
| Operating Cash Flow | $224.97MM | $195.18MM | $294.93MM |
| Capital expenditure | $220.03MM | $80.19MM | $81.07MM |
| Investing Cash Flow | $-227.91MM | $-89.54MM | $-130.39MM |
| Financing Cash Flow | $-13.11MM | $-95.59MM | $-50.94MM |
| Earnings Per Share** | $0.15 | $0.31 | $0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.